Reproductive Disorders: Male Flashcards

1
Q

General outline of reproductive axis in male

A
  • hypothalamus, pituitary, testes
  • Hypothalamus secretes GnRH in a pulsatile fashion (homeostatic pattern
  • Pituitary secretes FSH and LH in response to GnRH, also in a pulsatile fashion
    • LH stimulates Leydig cells to produce testosterone
    • FSH stimulates Sertoli cells which nurture maturing sperm
  • Testes/Gonads produce Testosterone, DHT, and Estradiol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pituitary role in reproductive axis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Testes/Gonads role in reproductive axis

A
  • Testes/Gonads produce Testosterone, DHT, and Estradiol
  • Testosterone.
    • Testosterone connects to Androgen receptors
    • Testosterone works throughout the body
  • DHT is made from Testosterone (5 α reductase) and
    • 5 α reductase is not located in all tissues
    • DHT acts locally on the external genitalia, hair follicles, sebaceous glands and prostate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Approach to disorders of hypothalamic-pituitary-gonadal (testicular) axis

A
  • multiple feedback loops exist between the hypothalamus (GnRH), the anterior pituitary (FSH, LH) and the testes.
    • Hypogonadism can result from a defect at any level of the HPG axis.
  • Disorders can be congenital or acquired and may include:
    • Mechanical causes (e.g. missing/damaged parts)
    • Hormonal causes such as a defect in GnRH, LH and/or FSH or testosterone production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Etiologies of hypogonadism

A
  • Hypogonadotropic Hypogonadism
    • Congenital vs. Acquired causes
  • Hypergonadotropic Hypogonadism
    • Congenital hypergonadotropic hypogonadism
    • Klinefelter’s Syndrome
    • Mutations in the androgen receptor
    • Acquired hypergonadotropic hypogonadism
    • Glycoprotein tumor of the pituitary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Congenital causes of hypogonadotropic hypogonadism

A
  • Hypogonadotropic Hypogonadism: ↓ LH + ↓ FSH + ↓ testosterone = impotence
  • Congenital cause → ↓ GnRH
  • Called Kallman syndrome if associated with anosmia
  • GnRH neurons never made it to hypothalamus when migrating from the olfactory placode
  • Think Kallman syndrome → Kan’t smell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acquired causes of hypogonadotropic hypogonadism

A
  • Two most common: High dose pain meds, Obstructive Sleep Apnea
  • High dose glucocorticoids
  • Severe Illness
  • Non Functioning pituitary tumor
    • Prolactinoma
    • Hemochromatosis
    • Hypothyroidism leads to ↑ prolactin
  • Surgery
  • Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lab results in acquired hypogonadotropic hypogonadism

A
  • Acquired causes of GnRH or LH and FSH deficits (much more common)
  • Low or low normal LH and FSH, and low testosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of congenital hypergonadotropic hypogonadism

A
  • Anorchism (absence of 1 or 2 testes) → some insult causes gonads to fail prior to 10-12 weeks gestation
  • ↑ FSH and ↑ LH result in attempt to grow the failed testes
  • ↓ Testosterone
  • Cryptorchidism → failure of testis to descend
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Characteristics of Klinefelter’s syndrome

A

–XXY: 1/400-1/1000 live births
–delayed puberty, eunuchoid body habitus, gynecomastia
–Low inhibin B levels
–Progressive tubular fibrosis, no sperm
–Eventual need for T replacement, mammograms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of Cryptocrchidism

A

n3% of newborn males (30% premies, 1% by 1 year)
nEtiologies: prematurity, low birth weight, SGA, twinning, maternal exposure to E in first trimester and rare genetic defects
nRisks: abnormal spermatogenesis, impaired fertility, increase in testicular cancer (15-fold unilateral, 33-fold bilateral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Characteristics of acquired hypergonadotropic hypogonadism

A
  • Trauma or torsion
  • Mumps orchitis
  • Alcohol: direct testicular toxin
  • Diabetes
  • Radiation/chemotherapy
  • Autoimmune testicular failure: check for other autoimmune diseases (TSH, glucose, B12, vit D)
  • Gonadotrope (nonfunctioning) pituitary tumors: hi FSH>LH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Characteristics of gonadotrope pituitary tumor

A

History: headaches, visual disturbance, erectile dysfunction

Exam: Visual fields, signs of hypogonadism, softening of testes

Labs: High FSH +/- LH and low T +/- mildly increased prolactin

Treatment: Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of treatment in male hypogonadism

A
  • androgens
  • gonadotropin therapy
  • pulsatile GnRH therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Characteristics of gonadotropin therapy

A
  • Gonadotropin therapy for hypothalamic or pituitary defects (central defects)
    • 12-18 mos nec. for maturation of testes and spermatogenesis
    • If no FSH production → human menopausal gonadotropin or recombinant FSH for duration of therapy
      *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Characteristics of pulsatile GnRH

A
  • Pulsatile GnRH therapy is available for GnRH defects in men.
  • Pump + catheter infuses supraphysiologic GnRH levels.
  • 18-24 months to recapitulate puberty and achieve sperm production
17
Q

Definition/pathophys of gynecomastia

A

Definition: palpable breast tissue in a male.

Pathophysiology: Disruption of balance of estrogen/androgen effects on breast tissue. Unopposed estrogen effects cause gynecomastia.

18
Q

Characteristics of testosterone tx in men

A

nTreat for signs sx and low T levels after confirming etiology
nT gels: 2.5, 5, 10 g daily (different concentrations, different application sites)
nT patch: 2, 4 mg daily
nDepoT: 200mg IM q 2-3wks (trough at 150-200 ng/dl), nonphysiologic highs and lows
nCBC, PSA watch for rise >1.5 ng/dl
nReassess risk benefit

19
Q

Etiologies of erectile dysfuncion

A

nVascular
nNeurogenic
nPsychogenic
nIatrogenic
nHormonal

20
Q

Sources of iatrogenic impotence

A

nAntihypertensives: beta blockers, diuretics, alpha blockers but not ACE inhibitors
nAndrogen receptor blockers: cimetidine, spironolactone
nPsych meds: all antipsychotic and antidepressants (SSRIs independent effects on libido)
nOther: metaclopramide (Reglan), cocaine, maryjuana, herbals

21
Q

Tx of erectile dysfxn

A

Psychotherapy: no randomized studies

Change meds, stop alcohol, improve systemic diseases

Drug therapy: type 5 phosphodiesterase inhibitors (sildenafil, vardenafil, tadenafil)

Penile injections: prostaglandin E

Vacuum pump device

22
Q
A